Vimarsana
Biggest News Aggregation in the World

Page 2 - Epigenetics Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Epigenetics Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Epigenetics Program Today - Breaking & Trending Today

Novel AI Blood Test Detects Liver Cancer - Vimarsana News

Novel AI Blood Test Detects Liver Cancer

A novel artificial intelligence blood testing technology has now detected more than 80% of liver cancers in a new study of 724 people. <br /><br />

Novel AI blood test detects liver cancer - Vimarsana News

Novel AI blood test detects liver cancer

The test, developed by researchers at the Johns Hopkins Kimmel Cancer Center, aids in early detection of liver cancer&#8212;one of the leading causes of cancer deaths

Source: jhu.edu
New AI blood testing technology detects more than 80% of liver cancers - Vimarsana News

New AI blood testing technology detects more than 80% of liver cancers

A novel artificial intelligence blood testing technology developed and used by Johns Hopkins Kimmel Cancer Center researchers to successfully detect lung cancer in a 2021 study has now detected more than 80% of liver cancers in a new study of 724 people.

Researchers receive NIH grant to develop mRNA vaccines to deter cancer development - Vimarsana News

Researchers receive NIH grant to develop mRNA vaccines to deter cancer development

A multidisciplinary team of Weill Cornell Medicine researchers have received a five-year $5.7 million grant from the National Cancer Institute at the National Institutes of Health to fund a center aimed at developing messenger RNA (mRNA) vaccines to deter cancer development in at-risk groups.

New tool discovers cancer-driving genes | Cornell Chronicle - Vimarsana News

New tool discovers cancer-driving genes | Cornell Chronicle

An advanced software tool for analyzing DNA sequences from tumor samples has uncovered likely new cancer-driving genes, in a study led by Weill Cornell Medicine researchers.